Chinese Biotechs Raise New Funds On Potential First-In-Class Assets

 
• By Dexter Jie Yan
  
funding
Chinese biotechs spearheading the development of first-in-class therapies have secured new modest-sized funding rounds • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business